Speaker
Co-Founder & Scientific Chief & Officer, Full Circles Therapeutics
Howard Wu, Co-Founder & Scientific Chief & Officer at Full Circles Therapeutics, spoke at 7th Genome Editing Therapeutics Summit 2026 (Boston, United States of America, 29–30 Sept 2026) in the session “Engineering Tripartite Cas9-ssDNA Binding Fusion Proteins to Enhance Non-Viral Targeted Genome Integration for Therapeutic Applications”.
29–30 Sept 2026Boston, United States of America
Senior Vice President, Research, Metagenomi Therapeutics
Associate Director, Sanofi
Senior Scientist, AbbVie
Senior Director, Scribe Therapeutics
Senior Director, Technical Operations, eGenesis Bio
Senior Director, Clinical Bioanalytics & Translational Science, Beam Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Howard Wu, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].